Kubota Pharmaceutical Holdings CO Ltd (KBBTF) financial statements (2022 and earlier)

Company profile

Business Address 4-20-3 EBISU
TOKYO, 150-0013
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments122,314112,010103,786
Cash and cash equivalents8,9495,08818,778
Short-term investments113,365106,92285,008
Receivables2,0556,1405,285
Deferred tax assets  61
Other undisclosed current assets2,9502,0512,582
Total current assets:127,319120,201111,714
Noncurrent Assets
Property, plant and equipment770920742
Long-term investments and receivables18,97554,51584,033
Long-term investments18,97554,51584,033
Other noncurrent assets319314435
Deferred tax assets, net  42
Total noncurrent assets:20,06455,74985,252
TOTAL ASSETS:147,383175,950196,966
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,4605,8026,300
Accounts payable439207441
Accrued liabilities1,7263,1384,176
Employee-related liabilities2,2952,4571,683
Deferred revenue and credits1532,6106,256
Total current liabilities:4,6138,41212,556
Noncurrent Liabilities
Liabilities, other than long-term debt9531,10447
Deferred revenue and credits9531,10447
Total noncurrent liabilities:9531,10447
Total liabilities:5,5669,51612,603
Stockholders' equity
Stockholders' equity attributable to parent141,817166,434184,363
Common stock207,449191,696186,589
Additional paid in capital 6,2883,601
Accumulated other comprehensive loss(132)(575)(361)
Accumulated deficit(65,500)(30,975)(5,466)
Total stockholders' equity:141,817166,434184,363
TOTAL LIABILITIES AND EQUITY:147,383175,950196,966

Income statement (P&L) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
Revenues
(Revenue, Net)
7,60624,06735,396
Gross profit:7,60624,06735,396
Operating expenses(43,602)(50,623)(35,584)
Operating loss:(35,996)(26,556)(188)
Nonoperating income1,4721,097541
Investment income, nonoperating1,4081,117519
Interest and debt expense  (15)
Other undisclosed income from continuing operations before equity method investments, income taxes  15
Income (loss) from continuing operations before income taxes:(34,524)(25,459)353
Income tax expense(1)(50)(2,359)
Net loss available to common stockholders, diluted:(34,525)(25,509)(2,006)

Comprehensive Income ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
Net loss:(34,525)(25,509)(2,006)
Comprehensive loss:(34,525)(25,509)(2,006)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent443(214)(354)
Comprehensive loss, net of tax, attributable to parent:(34,082)(25,723)(2,360)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: